Scopolamine Patch, Extended Release
Product Images NDC 71335-3013

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 71335-3013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713353013)

Scopolamine Transdermal System 1 mg/3 days patch label from Bryant Ranch Prepack. The label states the product contains 4 transdermal systems in a multipack, with active ingredient scopolamine formulated to deliver approximately 1 mg over 3 days. It includes storage instructions, cautionary statements, and manufacturer information (LTS Lohmann Therapie-Systeme AG).*

FDA Label Image

Extended Label (Lbl713353013extendedlabel)

This text panel titled 'Dosage and Administration' outlines five steps for using a Scopolamine transdermal patch. Instructions include washing hands before application, using only one patch at a time without cutting, removing the plastic backing, applying to the hairless area behind one ear, and washing hands after application.*

FDA Label Image

Chemical Structure (Scopolamine 01)

Chemical structure diagram of the active ingredient scopolamine showing its molecular framework with labeled functional groups.*

FDA Label Image

Image (Scopolamine 02)

An illustration showing the layered structure of a Scopolamine transdermal patch. The diagram labels five layers from top to bottom: Backing Membrane, Drug Layer, Rate Controlling Membrane, Contact Layer, and Release Liner. It visually represents the patch's design components.*

FDA Label Image

Figure 1 (Scopolamine 03)

An instructional diagram depicting a scopolamine transdermal patch with labeled components: a clear, disposable release liner; a metallic adhesive surface; and a tan backing membrane imprinted with "Scopolamine 1 mg/3 days." The patch is shown partially peeled back to illustrate these features.*

FDA Label Image

Figure 2 (Scopolamine 04)

An instructional illustration showing a sheet with text and a dotted line near the top, labeled "cut along dotted line." This figure appears to guide on how to cut or open the sheet, likely related to packaging or preparation instructions for the product.*

FDA Label Image

Figure 3 (Scopolamine 05)

An instructional illustration showing hands removing a circular transdermal patch from its backing. The image highlights the method of peeling the patch for application, relevant to the Scopolamine extended-release transdermal patch.*

FDA Label Image

Figure 4 (Scopolamine 06)

Illustration showing hands peeling a clear, disposable release liner from a tan-colored extended-release transdermal scopolamine patch with a metallic adhesive surface, highlighting the patch's components for application.*

FDA Label Image

Figure 5 (Scopolamine 07)

An instructional diagram showing the proper placement of a tan-colored transdermal Scopolamine patch behind the ear on a person's neck. The patch is labeled as an imprinted, tan-colored transdermal system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.